Journal article
Cardiac fibrosis in the ageing heart: Contributors and mechanisms
L Lu, J Guo, Y Hua, K Huang, R Magaye, J Cornell, DJ Kelly, C Reid, D Liew, Y Zhou, A Chen, W Xiao, Q Fu, BH Wang
Clinical and Experimental Pharmacology and Physiology | WILEY | Published : 2017
Abstract
Cardiac fibrosis refers to an excessive deposition of extracellular matrix (ECM) in cardiac tissue. Fibrotic tissue is stiffer and less compliant, resulting in subsequent cardiac dysfunction and heart failure. Cardiac fibrosis in the ageing heart may involve activation of fibrogenic signalling and inhibition of anti-fibrotic signalling, leading to an imbalance of ECM turnover. Excessive accumulation of ECM such as collagen in older patients contributes to progressive ventricular dysfunction. Overexpression of collagen is derived from various sources, including higher levels of fibrogenic growth factors, proliferation of fibroblasts and cellular transdifferentiation. These may be triggered by..
View full abstractRelated Projects (2)
Grants
Funding Acknowledgements
National Health and Medical Research Council of Australia, Grant/Award Number: Program Grant 1092642 and project grant 1087355